Dr. Bahl is investigating how the RasGRP1-mTORC1 pathway leads to an altered metabolic state in naïve T cells and how it functions in leukemia and other cancer types.
Characterizing a Novel RasGRP1-mTOR Pathway in Immune and Cancer Cells
Momentum Fellow (2020-2022)
Kriti Bahl, PhD, University of California, San Francisco
Kriti Bahl, PhD